ArticleJournal of eating disorders2026
Iatrogenic harm in eating disorder treatment: a lived experience-led call for epistemic justice and accountability.
Article in Journal of eating disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effectiveness without safety: a response to Duggan, Hardy, and Waller (2026).Journal of eating disorders · 2026Article
- Iatrogenic Harm, Psychotherapy, and Eating Disorders: An Urgent Call to Action.International journal of mental health nursing · 2026Article
- Iatrogenic harm and premature treatment discontinuation in eating disorders: a lived experience response to Wade and Schmidt (2026).Journal of eating disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychological treatments for eating disorders (EDs) can be beneficial, but treatment benefit is not, by itself, evidence of safety. A treatment may reduce ED symptoms while still causing iatrogenic harm (IH), and current evidence does not allow confident claims about whether IH is more common, less common, or as common as treatment benefit, because harms remain poorly defined, inconsistently monitored, and inadequately reported. This correspondence argues that the under-recognition of IH in ED care is not only a methodological problem, but also an epistemic one. When patients report being harmed or traumatised by treatment, their accounts may be dismissed, pathologised, or reframed as resistance, non-compliance, lack of insight, or treatment-interfering behaviour. Such responses can compound harm and prevent services from learning from patient testimony. The article further argues that IH is not experienced uniformly. Marginalised communities may encounter distinct forms of harm when treatment models are neuronormative, non-affirming, culturally incongruent, or inattentive to structural inequity. Person-centred ED care must therefore ask not only whether a treatment works on average, but for whom it is safe, meaningful, accessible, and accountable. The way forward requires prospective IH monitoring, patient-reported outcomes, open-ended and qualitative methods, repair-oriented practice, and lived experience-led co-design. Lived experience involvement is essential because people who have experienced harm can help define what counts as harm, which outcomes matter, how disclosures should be interpreted, and what accountability requires. Claims about the benefits or evidence-based status of psychological treatments for EDs are incomplete when safety is inferred from benefit or effectiveness alone while IH remains underdefined, undermeasured, and underreported.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.